Renin–angiotensin system polymorphisms interact with blood pressure in the determination of microalbuminuria in the general population

Journal of Human Hypertension

Volumn 20, Issue 3, 2006, Pages 235-237

  Titan, S M O ^a   Pereira, A C ^a   Cunha, R S ^b   Herkenhoff, F L ^b   Mill, J G ^b   Krieger, J E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALBUMINURIA; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; HYPERTENSION; LETTER; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; QUESTIONNAIRE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL MODEL;

ADULT; ALBUMINURIA; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RENIN-ANGIOTENSIN SYSTEM;

EID: 33745921773     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001968     Document Type: Article

References (12)

1. Damsgaard EM, Froland A, Jorgensen D, Mogensen CE. Microalbuminuria as a predictor of increased mortality in elderly people. BMJ 1990; 300: 297-300.
2. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: year observational study. BMJ 1996; 313: 779-784.
3. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in the general population. Circulation 2002; 106: 1777-1782.
4. Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch Intern Med 1998; 158: 1933-1939.
5. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 1997; 99: 1585-1595.
6. Pontremoli R, Ravera M, Viazzi F, Nicolella C, Berruti V, Leoncini G et al. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension. Kidney Int 2000; 57: 561-569.
7. Fernandez-Llama P, Poch E, Oriola J, Botey A, Rivera F, Revert L. Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: relation with target organ damage. Am J Hypertens 1998; 11: 439-444.
8. Pereira AC, Mota GF, Cunha RS, Herkenhoff FL, Mill JG, Krieger JE. Angiotensinogen 235T allele ‘dosage’ is associated with blood pressure phenotypes. Hypertension 2003; 41: 25-30.
9. Lessa I, Fonseca J. Race, compliance to treatment and/ or consultation and control of arterial hypertension. Arq Bras Cardiol 1997; 68: 443-449.
10. Mogensen CE, Viberti GC, Peheim E, Kutter D, Hasslacher C, HofmannWet al. Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care 1997; 20: 1642-1646.
11. Ramirez SPB, McClellan W, Port FK, Hong Hsu SI. Risk factors for proteinuria in a large, multiracial, Southeast Asian population. J Am Soc Nephrol 2002; 13: 1907-1917.
12. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13: 745-753.